期刊文献+

CDK4/6抑制剂在消化道肿瘤中的临床研究进展 被引量:2

Progress of Clinical Study of CDK4/6 Inhibitors in Gastrointestinal Tumors
原文传递
导出
摘要 细胞周期蛋白依赖性激酶(cyclin dependent kinase,CDK)4/6抑制剂在阻止肿瘤生长、疾病发展和提高存活率方面显示出显著的效果,是目前抗肿瘤药物研发的热点,临床上已用于乳腺癌和非小细胞肺癌的治疗。CDK4/6在消化道肿瘤中有扩增和过度表达,CDK4/6抑制剂在消化道肿瘤中已陆续展开临床试验,本文就近期CDK4/6抑制剂在食管癌、胃癌、结直肠癌中的临床试验情况进行综述。 Cyclin dependent kinase(CDK)4/6 inhibitors have shown significant effects in preventing tumor growth, disease development, and improving survival rates. They are currently a hot spot in the research and development of anti-cancer drugs and have been clinically applied in the treatment of breast cancer and non-small cell lung cancer. CDK4/6 is amplified and overexpressed in gastrointestinal tumors. CDK4/6 inhibitors have been studied in gastrointestinal tumors. This article reviews the recent clinical trials of CDK4/6 inhibitors in esophageal cancer, gastric cancer, and colorectal cancer.
作者 刘艳华 王明权 朱伟英 卢燕君 王文佳 LIU Yanhua;WANG Mingquan;ZHU Weiying;LU Yanjun;WANG Wenjia(Hangzhou Simbos Pharm Co.,Ltd.,Hangzhou 311121,China;Hangzhou Kewan New Material Technology Co.,Ltd.,Lin’an 311305,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2021年第18期2333-2336,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 CDK4/6抑制剂 临床试验 食管癌 胃癌 结直肠癌 CDK4/6 inhibitors clinical trial esophageal cancer gastric cancer colorectal cancer
  • 引文网络
  • 相关文献

参考文献2

二级参考文献13

  • 1郑美蓉,阮庆大,程玲,胡志红,梁淑凡,吴萍.CyclinD1、CyclinE、CDK6在原发性肝细胞癌中的表达[J].临床肝胆病杂志,2006,22(1):49-51. 被引量:7
  • 2Jemal A,Siegel R,Ward E. Cancer statistics,2008[J].CA:A Cancer Journal for Clinicians,2008,(02):71-96.
  • 3Takaki T,Fukasawa K,Suzuki-Takahashi I. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases,Cdk4 and CDK6,in vitro[J].Biochemical Journal,2005,(03):381-386.
  • 4Schlüter C,Duchrow M,Wohlenberg C. The cell proliferation-associated antigen of antibody Ki-67:a very large,ubiquitous nuclear protein with numerous repeated elements,representing a new kind of cell cycle-maintaining proteins[J].Journal of Cell Biology,1993,(03):513-522.
  • 5Stanley R;Hamilton Lauri A.Aaltonen.Pathology and Genetics in tumours of the Digestive System[M]北京:人民卫生出版社,2006124-131.
  • 6中国抗癌协会.新编常见恶性肿瘤诊治规范大肠癌分册[M]北京:北京医科大学中国协和医科大学联合出版社,1999.
  • 7Kawasaki H,Altieri DC,Lu CD. Inhibition of a PoPtosis by survivin Prediets shorter survival rates in colorectalcancer[J].Cancer Research,1998,(22):5071-5074.
  • 8SinicroPe FA,Ruan SB,Cleary KR. Bcl-2 and P53 oncoprotein expressionduring colorectal tumorigenesis[J].Cancer Research,1995,(02):237-241.
  • 9Duman-Scheel M,Weng L,Xin S. Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E[J].Nature,2002,(6886):299-304.
  • 10Meyerson M,Harlow E. Identification of G1 kinase activity for cdk6,a novel cyclin D partner[J].Molecular and Cellular Biology,1994,(03):2077-2086.

共引文献8

同被引文献15

引证文献2

二级引证文献3

;
使用帮助 返回顶部